Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
about
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoArguing the misconceptions in allergen-specific immunotherapy.Allergy--current insights into prevention and diagnostic workup of immediate-type allergy and treatment of allergic rhinoconjunctivitis.Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
P2860
Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunologic effect and tolerab ...... zed, placebo-controlled trial.
@en
type
label
Immunologic effect and tolerab ...... zed, placebo-controlled trial.
@en
prefLabel
Immunologic effect and tolerab ...... zed, placebo-controlled trial.
@en
P2093
P1476
Immunologic effect and tolerab ...... zed, placebo-controlled trial.
@en
P2093
Eike Wüstenberg
Hendrik Wolf
Jörg Schnitker
Ludger Klimek
Oliver Pfaar
P304
P356
10.1016/J.CLINTHERA.2012.09.006
P577
2012-10-01T00:00:00Z